Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS

• Status: Completed
• Trial end date: 2019-11-20
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this work is to study the value of GnRH antagonist subcutaneous administration as an alternative to coasting in prevention of severe OHSS and its impact on embryos quality & the outcome of ICSI.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: ClinAmygate
• Collaborators: Al-Azhar University; Beni-Suef University; Cairo University
• Treatments: Cetrorelix

Criteria

Inclusion Criteria:

• infertile women

• age 20-40

• at high risk for OHSS

Exclusion Criteria:

• refuse to participate